Login / Signup
Ali Hajigholami
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Double Blind
Phase Iii
Study Protocol
Childhood Cancer
Top Venues
BMC complementary medicine and therapies
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Safoora Sadat Erfanian
,
Hourieh Ansari
,
Shaghayegh Haghjooy Javanmard
,
Zahra Amini
,
Ali Hajigholami
The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial.
BMC complementary medicine and therapies
24 (1) (2024)